On April 27, 2026, P3 Health Partners Inc. entered into a Debt Exchange Agreement, converting approximately $252.5 million of debt into preferred stock, ensuring compliance with Nasdaq's equity requirements. Additionally, they issued $10 million in preferred stock under a Securities Purchase Agreement, designed to further strengthen their capital structure.